James M. Mock - 05 Oct 2026 Form 4 Insider Report for Moderna, Inc. (MRNA)

Reporting relationship: Chief Financial Officer
Issuer ticker: MRNA
Reported as of: 05 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Oct 2026, 16:04:45 UTC
Prior SEC filing: 14 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ James Dillon, As Attorney-in-Fact

Filing notes and source

Key filing fact

James M. Mock filed Form 4 for Moderna, Inc. (MRNA) on 07 Oct 2026.

Key facts

This page summarizes James M. Mock's Form 4 filing for Moderna, Inc. (MRNA).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Oct 2026, 16:04.

Change

Previous filing in this sequence was filed on 14 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001736359 Primary reporting owner

Mock James M

Relationship: Chief Financial Officer
Address: C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE
Signature: /s/ James Dillon, As Attorney-in-Fact
Signature date: 07 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRNA transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,454
Change %: +2.4%
Price
Shares after: 60,829
Date: 05 Oct 2026
Ownership: Direct
Footnotes: F1

MRNA transaction

Common Stock

Tax liability

Transaction value
Shares: -704
Change %: -1.2%
Price: $190.01^*
Shares after: 60,125
Date: 05 Oct 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MRNA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -1,454
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 05 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,454
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.

Footnote F3

25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.